Microbicides & HIV/AIDS: News & Research
- African Scientists' Search for Female-Controlled Microbicide Gel to Prevent HIV Continues (February 3, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- HIV Trial Scrapped After Gel Found to Be Ineffective (November 29, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 Vaginal Gel Study Discontinued: A Blog Entry by Candace Y.A. Montague (November 28, 2011)
"The National Institutes of Health NIAID announced Friday that it will discontinue the trial of a microbicidal vaginal gel used in the VOICE study."
From The Body
- Pivotal HIV Prevention Trial for Women in Africa Finds That Use of Tenofovir Gel Does Not Prevent HIV: What Does This Mean for HIV Prevention for Women? (November 28, 2011)
Global Campaign for Microbicides statement on the VOICE DSMB decision to discontinue use of tenofovir gel.
From Global Campaign for Microbicides
- NIH Discontinues Tenofovir Vaginal Gel in "VOICE" HIV Prevention Study (November 25, 2011)
Product safe but no more effective than placebo.
From U.S. National Institutes of Health
- VOICE Trial Changes Are Disappointing, Says AVAC; Calls for Continued Research to Find New Prevention Options for Women (November 25, 2011)
To read PDF, click here.
From AIDS Vaccine Advocacy Coalition
- First Clinical Trial of ARV Vaginal Ring Underway (November 23, 2011)
In Positively Aware, from Test Positive Aware Network
- Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South Africa (October 24, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 Another Study Finds That Microbicides Cut Women's Herpes Risk (October 23, 2011)
From The Body
- NIH Researchers Show How Anti-HIV Drug Acts to Block Herpes Virus (October 20, 2011)
Newfound effectiveness of tenofovir due to higher concentrations in vaginal gel form.
From U.S. National Institutes of Health
- Microbicide Trials Network Stops Tenofovir Arm of Study After Findings Show Drug Less Effective Than Anticipated (September 29, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 NIH Modifies "VOICE" HIV Prevention Study in Women (September 28, 2011)
Oral tenofovir discontinued in clinical trial.
From U.S. National Institute of Allergy and Infectious Diseases
 In Order to Be Effective, Do Microbicides Have to Be Sexually Pleasurable? (September 7, 2011)
From The Body
- Preventive Technologies, Immune-Based and Gene Therapies and Research Toward a Cure (September 2011)
In 2011 Pipeline Report, from Treatment Action Group and HIV i-Base
- Tenofovir Microbicide Reduces Women's HIV Risk (Summer/Fall 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Joint Venture to Manufacture and Distribute Tenofovir Gel in Africa (June 16, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Large Trial of Tenofovir Gel for Women Set to Begin in South Africa (June 15, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Microbicides Follow-Up Clinical Trials Finally Announced (June 14, 2011)
In Business Live
- New Contraceptive in the Pipeline (May 5, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AIDS Gel Shown to Protect Anal Tissue From HIV (February 28, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Preventing HIV: New Tools, New Hope (Winter 2010/2011)
To read PDF, click here.
In Achieve, from ACRIA and GMHC
- 2011: 10 HIV Stories to Watch, Part 2 (January 26, 2011)
In Black AIDS Weekly, from Black AIDS Institute
- Experimental NNRTI-Based Microbicide Gel Prevents HIV Infection in Monkeys (January 6, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Microbicide Field Wrestles With the Implications of Success -- an Update (Winter 2011)
To read PDF, click here.
In TAGline, from Treatment Action Group
- MedPage Today Examines Recent Developments, Trials Underway in HIV Prevention (December 24, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- U.S. Considers New Tools in Global AIDS Fight (December 16, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- CAPRISA: A Home Run (or at Least a Base Hit) for a Microbicide (December 8, 2010)
Part of "Top HIV/AIDS-Related Clinical Developments of 2010," by David Wohl, M.D.
From The Body
- The Role of ARVs in HIV Prevention: Microbicides and PrEP (December 2010)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- New Lines of Attack in HIV Prevention (November 12, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Canada: Grant From Gates Foundation Will Aid Development of Revolutionary New Contraceptive (November 10, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New York Times Examines HIV Prevention Products Undergoing Clinical Trials (November 9, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Reuters Examines Development Progress of Microbicide Gel to Prevent HIV (October 27, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- In Clinical Trial, Vaginal Gel PRO 2000 Found "Safe but Ineffective" at Preventing HIV Infection (September 20, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Experts Gathered for UNAIDS, WHO Meeting Recommend Follow-Up Studies of ARV-Containing Microbicide Gel Start Soon (September 7, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Experts Gather in Philadelphia to Discuss AIDS in Black Communities (August 30, 2010)
In Black AIDS Weekly, from Black AIDS Institute
- Finding Our Voices, Claiming Our Power (August 23, 2010)
In Black AIDS Weekly, from Black AIDS Institute
- New York Times Examines Questions Left Unanswered by Microbicide Trial (July 27, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- AIDS 2010: Researchers Moving Toward HIV/AIDS Treatments and Cures (July 22, 2010)
From Black AIDS Institute
- South Africa Eager to See Speedy Roll-Out of AIDS Gel (July 22, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Understanding HIV Transmission Mechanisms: Microbicides and PrEP (July 22, 2010)
To read PDF, click here.
From Henry J. Kaiser Family Foundation
- Microbicides and Circumcision Could Achieve Modest Cuts in HIV Infections in Africa (July 22, 2010)
From aidsmap.com
- Monumental AIDS Breakthrough -- Or Is it? (July 21, 2010)
In The Huffington Post
- Husband and Wife May "Alter the Course of the HIV Epidemic" (July 21, 2010)
In Black Spin, from Black Voices
- Safety and Effectiveness of 1% Tenofovir Vaginal Microbicide Gel in South African Women: Results of the CAPRISA 004 Trial (July 20, 2010)
To read PDF, click here.
From Henry J. Kaiser Family Foundation
- Q&A: Drs. Salim and Quarraisha Abdool Karim, Breakthrough Microbicide Researchers (July 20, 2010)
From Black AIDS Institute
- AIDS 2010: Study Finds Microbicide Containing HIV Drug Lowers Infection Risk in Women By 39% (July 20, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Success for Microbicide (July 20, 2010)
A vaginal microbicide gel containing the anti-HIV drug tenofovir (Viread) reduces the risk of infection with HIV for women using it by 39%, results of a study have shown.
From aidsmap.com
- CDC Statement on CAPRISA Microbicide Study Results (July 19, 2010)
From U.S. Centers for Disease Control and Prevention
- Statement of Anthony S. Fauci, M.D., Director, NIAID, NIH, on Results From the CAPRISA 004 Microbicide Study (July 19, 2010)
From National Institute of Allergy and Infectious Diseases
- Future Priorities for NIAID's HIV Prevention Research: A Blog Entry by Carl W. Dieffenbach, Ph.D. (June 21, 2010)
From U.S. National Institute of Allergy and Infectious Diseases
- Why Rectal Douches May Be Acceptable Rectal-Microbicide Delivery Vehicles for Men Who Have Sex With Men (June 18, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Washington Post Examines Trial in Africa of Long-Acting Vaginal Ring for HIV Prevention (June 15, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Africa: New Vaginal Ring Borrows From Birth Control to Fight AIDS (June 10, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- KPBS Examines Microbicide Research as M2010 Concludes (May 26, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Researchers Present More Findings for Microbicides, PrEP at M2010 Conference (May 25, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Media Outlets Highlight Studies Presented at International Microbicides Conference (May 24, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Latest Attempt to Block HIV: Stronger Vaginal Gels (May 21, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AP Examines HIV Microbicides, PrEP Research (May 18, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- From Promise to Product: Advancing Rectal Microbicide Research and Advocacy (PDF) (May 2010)
From International Rectal Microbicide Advocates
- Bananas Over BanLec (March 16, 2010)
From Treatment Action Group
- Future of AIDS Gels May Lie in Drugs, Experts Say (March 8, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- PRO 2000 Microbicide Proves Ineffective (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- News Outlets Examine Use of ART, Microbicide Development Presented at Conference (February 22, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Maraviroc Showing Tantalising Promise as Microbicide in Preclinical Studies (February 19, 2010)
From aidsmap.com
- Disappointing Results for a Promising Microbicide (February 2010)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Microbicide Does Not Reduce Women's Risk of HIV Infection, Study Shows (December 14, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Blog: U.S.-E.U. Antimicrobial Resistance Task Force Has Promise (November 13, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Got Lube? (November/December 2009)
The slippery slope for African men who don't.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- An HIV-Blocking Gel for Women (August 10, 2009)
New "molecular condom" meant to prevent AIDS.
From University of Utah
- Microbicide Under Research for HIV Prevention Examined (August 5, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Early Tests of Maraviroc as Microbicide Produce Less Activity Than Expected (July 23, 2009)
Preclinical ex-vivo tests of the entry inhibitor drug maraviroc as a possible microbicide have found that the drug only produced a moderate protective effect against HIV: a 50% to 60% inhibition of HIV infection of penile tissue and an 85% inhibition in colorectal tissue, when given at high doses.
From aidsmap.com
- Prevention, Vaccines Addressed at IAS Conference (July 22, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Green Tea Cream Could Hold a Key to Blocking HIV Infection, Study Suggests (May 19, 2009)
A compound in green tea appears to neutralize a protein in semen that enhances semen's ability to transmit viruses, including HIV.
From Agence France-Presse
- Use of Certain Antibiotics in Topical Cream Could Prevent HIV Transmission, Study Says (April 29, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Protein Grown in Tobacco Plant Could Result in Low-Cost Microbicide, Study Says (April 1, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Scientists Debate HIV Prevention Products (March 13, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Microbicide Containing Natural Compound Provides Protection in Monkeys Against Simian Version of HIV, Study Says (March 5, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Microbicides: Failure and Success (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Microbicide Development: Positive Women's Concerns (Winter/Spring 2009)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Experimental Microbicide Shows Small Level of Protection Against HIV for Women, Study Presented at CROI Indicates (February 10, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Human Trial of Microbicide Gels Finds Promise for PRO 2000, Not for BufferGel: Press Conference Transcript (February 9, 2009)
Salim Abdool Karim, M.D., Ph.D., reveals that PRO 2000 appeared to confer 30% protection compared to placebo in women using the gel as a vaginal microbicide, though the results failed to reach statistical significance. Meanwhile, another microbicide candiate, BufferGel, failed to show any protective effect whatsoever.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Human Trial of Vaginal Microbicide Gel PRO 2000 Finds Some Level of HIV Protection (February 9, 2009)
Salim Abdool Karim, M.D., Ph.D., reveals that PRO 2000 appeared to confer 30 percent protection compared to placebo in women using the gel as a vaginal microbicide, though the results failed to reach statistical significance. Meanwhile, another microbicide candidate, BufferGel, failed to show any protective effect whatsoever.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Anti-HIV Gel Shows Promise in Large-Scale Study in Women (February 9, 2009)
From National Institute of Allergy and Infectious Diseases
- Virginia School's Research on HIV Continues After Drug Setback (February 4, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Carraguard Ineffective for Preventing HIV Transmission, Study Finds; Researchers Say That Microbicide Research Should Continue (December 9, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Merck Provides International Partnership With Experimental Drug to Develop Microbicide (March 13, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- South African Trial of HIV Drug Disappoints (February 19, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Researchers Use Technique to Identify, Generate Molecules for Microbicide Research, Development (February 6, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- IPM Reaches Landmark Agreement With Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide (January 30, 2008)
From International Partnership for Microbicides
- Highlights of Biomedical Prevention Strategies (November/December 2007)
Methods to prevent HIV from the angle of biology offer hope.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Microbicide Candidate Ushercell Not Effective in Preventing HIV (July 27, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Lemon Juice Not a Killer Weapon in Fight Against HIV (July 24, 2007)
In The Age
- Trials Begin on HIV Gel for Women (July 10, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- International Community Must Increase Efforts to Prevent Spread of HIV Among Women, Opinion Piece Says (June 10, 2007)
From Medical News Today
- Uganda: Women Call for Own HIV Measures (June 10, 2007)
From allAfrica.com
- South Africa: High Hopes for ARV-Based Gel (June 4, 2007)
From allAfrica.com
- Ongoing Microbicide Clinical Trials (By Product) (PDF) (May 17, 2007)
From Alliance for Microbicide Development
- Planned Microbicide Clinical Trials (PDF) (May 16, 2007)
From Alliance for Microbicide Development
- Microbicide Clinical Trials: Are They Ethical? (PDF) (March 2007)
From Global Campaign for Microbicides
- Evaluating the Safety of Vaginal Microbicides: The Fundamentals (PDF) (March 2007)
From Global Campaign for Microbicides
- International AIDS Society Hails Cancellation of Ushercell Microbicide Trials, Notes That More Candidates Are in Advanced Development (February 1, 2007)
From International AIDS Society
- Statement on the Closing of Cellulose Sulfate Gel Trials Due to Concerns of Potential Increased Risk of HIV Infection (January 31, 2007)
From International Partnership for Microbicides
- Early Tests Promising for Algae-Based Microbicide (January 16, 2007)
In BBC News Online
- Cellegy Ends Phase III Microbicide Trial in Nigeria (August 29, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- The Latest on Microbicides: Highlights From the Microbicides 2006 Conference (April 27, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Effective Microbicide Could Be Available by 2010, Researchers Say (April 24, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- FDA Grants Accelerated Review of Microbicide Developed by Australian Pharmaceutical Company (January 10, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Agreement Paves Way for Use of Experimental Entry Inhibitors in Microbicide Development (November 1, 2005)
[Archived Article]
In San Francisco Chronicle
- Drug Companies Agree to License Experimental Entry Inhibitors for Use by Microbicide Researchers (November 1, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Effective, Female-Controlled Barriers on the Way, Researchers Say (August 15, 2005)
[Archived Article]
Summary of a review published in the journal Sexually Transmitted Infections.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New Agreement Will Speed Research Efforts on Microbicides for Women (August 4, 2005)
[Archived Article]
NIAID and the International Partnership for Microbicides announce plans to share information and expertise.
From U.S. National Institute of Allergy and Infectious Diseases
- Spermicide Gel C31G Also Might Kill HIV, Doctors Say (July 6, 2005)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Prevalence Rises in Swaziland Despite Efforts to Fight Disease (May 24, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Microbicide Pilot Study Shows Promise in Women (March 9, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Microbicide Research Speeds Up; Approval May Be Five Years Away (July 14, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Report From the HIV Prevention Leadership Summit, Atlanta, Ga., June 16-19, 2004 (June 25, 2004)
[Archived Article]
Recaps of several workshops and roundtables from this four-day meeting, which focused primarily on challenges to implementing new government guidelines on HIV prevention.
In AIDS Action Weekly Update, from AIDS Action Council
- Johnson & Johnson Passes Rights for Experimental Microbicide to Global Group (March 30, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Interview With Robin Shattock, M.D., on Microbicides (Winter 2003/2004)
[Archived Article]
Dr. Shattock is a researcher with St. George's Hospital Medical School in London.
In Positives for Positives, from Wyoming: Positives for Positives
- FDA Discusses Clinical Trial Designs for Microbicide Research (September 2003)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- FDA Panel Meets to Discuss Ways to Test Safety, Efficacy of Experimental Microbicides to Prevent HIV Transmission (August 21, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Phase II Trial With PRO 2000 to Prevent HIV Transmission Begins in Africa (August 20, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Microbicide Gel to Begin Human Trials in Late 2003 (August 4, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Microbicide Gel PRO 2000 Found Safe in Trials (June 2, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Australia: Gel May Be Sexual Disease Barrier (March 21, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- University of Pittsburgh Medical Center Awarded Grant for Research in HIV Prevention (January 13, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Vaginal Contraceptive/HIV Fighter Seems Promising (December 6, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Potential AIDS Preventive Doubles as a Contraceptive (November 13, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Seaweed Compound's Anti-HIV Efficacy Will Be Tested in Southern Africa (May 24, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Practical Prevention of Vaginal and Rectal Transmission of HIV by Adapting the Oral Defense: Use of Commercial Lubricants (October 2001)
[Archived Article]
In Body Positive, from Body Positive
- Diaphragm and Microbicide Combination May Work to Block HIV (September 21, 2001)
[Archived Article]
In STEP Ezine, from Seattle Treatment Education Project
- Nonoxynol-9 Not Effective Microbicide, Trial Shows (June 13, 2000)
[Archived Article]
From UNAIDS
- Feasible Microbicides Remain Elusive (Summer 2000)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- NIAID Topical Microbicide Research Fact Sheet (March 2000)
[Archived Article]
Developing new tools to protect women from HIV/AIDS and other STDs.
From U.S. National Institute of Allergy and Infectious Diseases
|
Advertisement
|
Email
Glossary
